Implementation of scaled and centralized production of viral vectors for the manufacture of varnimcabtagene autoleucel (var-cel) for its commercial development and international expansion.

The purpose of INVECTO is to support the national and international expansion of the academic Chimeric Antigen Receptor T cell (CAR-T) product varnimcabtagene autoleucel (var-cel). INVECTO aims at establishing at Gene Vector the centralized and scaled manufacturing in bioreactors of the lentiviral vectors to produce the CAR-T cell therapy var-cel; and to support the point-of-care manufacturing of var-cel in collaboration with academic institutions.